Apollo Therapeutics closes Series C financing at $260 million
Drug Discovery World
JANUARY 16, 2024
The company was initially founded as partnership between three research organisations, Cambridge University, Imperial College London and University College London, and three pharmaceutical companies, AstraZeneca, GSK and J&J. “We
Let's personalize your content